Llista de publicacions més recents liderades per la Unitat de Memòria de l’Hospital de Sant Pau:
- Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests. Benejam, B, Videla, L, Vilaplana, E et al. Alzheimers Dement (Amst) 2020PMID:32613076
- Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Fortea, J, Vilaplana, E, Carmona-Iragui, M et al. Lancet 2020PMID:32593336
- Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders. Delaby, C, Alcolea, D, Carmona-Iragui, M et al. Sci Rep 2020PMID:32514050
- Assessing circular RNAs in Alzheimer's disease and frontotemporal lobar degeneration. Cervera-Carles, L, Dols-Icardo, O, Molina-Porcel, L et al. Neurobiol. Aging 2020PMID:32335360
- Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's Disease. Cantero, JL, Atienza, M, Lage, C et al. Cereb. Cortex 2020PMID:31799623
- APP-derived peptides reflect neurodegeneration in frontotemporal dementia. Illán-Gala, I, Pegueroles, J, Montal, V et al. Ann Clin Transl Neurol 2019PMID:31789459
- The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders. Alcolea, D, Clarimón, J, Carmona-Iragui, M et al. Alzheimers Dement (N Y) 2019PMID:31650016
- Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse. Alcolea, D, Pegueroles, J, Muñoz, L et al. Ann Clin Transl Neurol 2019PMID:31464088
- Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosis. Carmona-Iragui, M, Videla, L, Lleó, A et al. Dev Neurobiol 2019PMID:31278851
- Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease. Morenas-Rodríguez, E, Alcolea, D, Suárez-Calvet, M et al. Sci Rep 2019PMID:31127154
- Nanoscale structure of amyloid-β plaques in Alzheimer's disease. Querol-Vilaseca, M, Colom-Cadena, M, Pegueroles, J et al. Sci Rep 2019PMID:30914681
- Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy. Illán-Gala, I, Montal, V, Borrego-Écija, S et al. Brain 2019PMID:30906945
- Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid. Lleó, A, Núñez-Llaves, R, Alcolea, D et al. Mol. Cell Proteomics 2019PMID:30606734
- Impact of CSF storage volume on the analysis of Alzheimer's disease biomarkers on an automated platform. Delaby, C, Muñoz, L, Torres, S et al. Clin. Chim. Acta 2019PMID:30579960
- Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging study. Pegueroles, J, Jiménez, A, Vilaplana, E et al. Oncotarget 2018PMID:30410669
- Prevalence of Sleep Disorders in Adults With Down Syndrome: A Comparative Study of Self-Reported, Actigraphic, and Polysomnographic Findings. Giménez, S, Videla, L, Romero, S et al. J Clin Sleep Med 2018PMID:30353801
- Elevated YKL-40 and low sAPPβ:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD. Alcolea, D, Irwin, DJ, Illán-Gala, I et al. J. Neurol. Neurosurg. Psychiatry 2019PMID:30297518
- CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum. Illán-Gala, I, Alcolea, D, Montal, V et al. Neurology 2018PMID:30291183
- Challenges associated with biomarker-based classification systems for Alzheimer's disease. Illán-Gala, I, Pegueroles, J, Montal, V et al. Alzheimers Dement (Amst) 2018PMID:30175226
- Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Fortea, J, Carmona-Iragui, M, Benejam, B et al. Lancet Neurol 2018PMID:30172624
- Clinical Subtypes of Dementia with Lewy Bodies Based on the Initial Clinical Presentation. Morenas-Rodríguez, E, Sala, I, Subirana, A et al. J. Alzheimers Dis. 2018PMID:29889064
- Cerebral changes and disrupted gray matter cortical networks in asymptomatic older adults at risk for Alzheimer's disease. Cantero, JL, Atienza, M, Sanchez-Juan, P et al. Neurobiol. Aging 2018PMID:29331877
- Weight loss in the healthy elderly might be a non-cognitive sign of preclinical Alzheimer's disease. Jimenez, A, Pegueroles, J, Carmona-Iragui, M et al. Oncotarget 2017PMID:29285207
- Alzheimer's disease: An ignored condition. Lleó, A Med Clin (Barc) 2018PMID:29196039
- Synaptic phosphorylated α-synuclein in dementia with Lewy bodies. Colom-Cadena, M, Pegueroles, J, Herrmann, AG et al. Brain 2017PMID:29177427
- Cortical microstructural changes along the Alzheimer's disease continuum. Montal, V, Vilaplana, E, Alcolea, D et al. Alzheimers Dement 2018PMID:29080407
- Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the C9orf72 expansion mutation. Dols-Icardo, O, García-Redondo, A, Rojas-García, R et al. J. Neurol. Neurosurg. Psychiatry 2018PMID:28889094
- The pitfalls of biomarker-based classification schemes. Illán-Gala, I, Vilaplana, E, Pegueroles, J et al. Alzheimers Dement 2017PMID:28704640
- YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer's disease and other tauopathies. Querol-Vilaseca, M, Colom-Cadena, M, Pegueroles, J et al. J Neuroinflammation 2017PMID:28599675
- CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration. Alcolea, D, Vilaplana, E, Suárez-Calvet, M et al. Neurology 2017PMID:28592456